Usa covid-19 economy patient symptomatic Usa

Acer Therapeutics, NCATS partner to develop emetine for Covid-19

Reading now: 531
www.pharmaceutical-technology.com

Pharmaceutical company Acer Therapeutics has partnered with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride for the potential treatment of Covid-19 patients.

Under the research collaboration agreement, the partners will work together to speed-up the clinical development of emetine, which showed broad and potent antiviral activity in preclinical and clinical studies.

Currently, Acer Therapeutics is in discussions with the US Food and Drug Administration (FDA)’s Division of Antivirals (DAV) following initial responses to its pre-investigational new drug (pre-IND) filing.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA